Success Metrics

Clinical Success Rate
91.6%

Based on 109 completed trials

Completion Rate
92%(109/119)
Active Trials
41(17%)
Results Posted
2%(2 trials)
Terminated
10(4%)

Phase Distribution

Ph phase_2
9
4%
Ph phase_4
4
2%
Ph phase_1
2
1%
Ph not_applicable
83
34%
Ph early_phase_1
3
1%
Ph phase_3
3
1%

Phase Distribution

5

Early Stage

9

Mid Stage

7

Late Stage

Phase Distribution104 total trials
Early Phase 1First-in-human
3(2.9%)
Phase 1Safety & dosage
2(1.9%)
Phase 2Efficacy & side effects
9(8.7%)
Phase 3Large-scale testing
3(2.9%)
Phase 4Post-market surveillance
4(3.8%)
N/ANon-phased studies
83(79.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.5%

109 of 126 finished

Non-Completion Rate

13.5%

17 ended early

Currently Active

41

trials recruiting

Total Trials

244

all time

Status Distribution
Active(61)
Completed(109)
Terminated(17)
Other(57)

Detailed Status

Completed109
unknown57
Recruiting33
Not yet recruiting16
Terminated10
Active, not recruiting8

Development Timeline

Analytics

Development Status

Total Trials
244
Active
41
Success Rate
91.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (2.9%)
Phase 12 (1.9%)
Phase 29 (8.7%)
Phase 33 (2.9%)
Phase 44 (3.8%)
N/A83 (79.8%)

Trials by Status

terminated104%
unknown5723%
withdrawn73%
active_not_recruiting83%
recruiting3314%
completed10945%
enrolling_by_invitation42%
not_yet_recruiting167%

Recent Activity

Clinical Trials (244)

Showing 20 of 244 trialsScroll for more
NCT06779916

Autophagy/Apoptosis Balance in Placental Vascular Pathologies

Recruiting
NCT07564752

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

Recruiting
NCT03581695

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension

Completed
NCT06863974Not Applicable

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

Recruiting
NCT07550777

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

Recruiting
NCT04974892

Aspirin and Neutrophils in Preeclampsia

Completed
NCT07545174Not Applicable

Role of the Environment in Pediatric Obesity

Not Yet Recruiting
NCT04786587

Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.

Recruiting
NCT07090291Not Applicable

China Colorectal Cancer Screening Trial 1 (C-Cost1)

Recruiting
NCT07514715

Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas

Not Yet Recruiting
NCT00565513Not Applicable

Cryptorchidism: Impact of in Utero Exposure to Xenobiotics With Hormonal Action

Completed
NCT05461092Early Phase 1

Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion

Recruiting
NCT03654105Phase 2

Screening and Multiple Intervention on Lung Epidemics

Active Not Recruiting
NCT05651919

PBMC as Biomarkers of Diabetic Cardiomyopathy

Recruiting
NCT05766046Not Applicable

Lung Cancer Prevention Screening Programme in Italy

Active Not Recruiting
NCT05024175

Long-term Follow-up of Subjects Treated With CAR T Cells

Recruiting
NCT04024150

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn

Completed
NCT04786223Phase 2

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

Enrolling By Invitation
NCT05939752

Cardiovascular Complications of Ibrutinib Therapy

Terminated
NCT03568188Phase 2

Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
244